| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.5 |